Related Experiment Video
Updated: Apr 15, 2026

A Rapid In Vivo Bioassay for Developmentally Active Enhancers
A cohesin-OCT4 complex mediates Sox enhancers to prime an early embryonic lineage
Nesrine Abboud1, Thomas Moore- Morris2, Emilye Hiriart1,2
1INSERM UMR 633, Genopole Evry, University Paris Descartes, 91000 Evry, Paris, France.
Abstract:
Short- and long-scales intra- and inter-chromosomal interactions are linked to gene transcription, but the molecular events underlying these structures and how they affect cell fate decision during embryonic development are poorly understood. One of the first embryonic cell fate decisions (that is, mesendoderm determination) is driven by the POU factor OCT4, acting in concert with the high-mobility group genes Sox-2 and Sox-17. Here we report a chromatin-remodelling mechanism and enhancer function that mediate cell fate switching. OCT4 alters the higher-order chromatin structure at both Sox-2 and Sox-17 loci. OCT4 titrates out cohesin and switches the Sox-17 enhancer from a locked (within an inter-chromosomal Sox-2 enhancer/CCCTC-binding factor CTCF/cohesin loop) to an active (within an intra-chromosomal Sox-17 promoter/enhancer/cohesin loop) state. SALL4 concomitantly mobilizes the polycomb complexes at the Soxs loci. Thus, OCT4/SALL4-driven cohesin- and polycombs-mediated changes in higher-order chromatin structure mediate instruction of early cell fate in embryonic cells.
Related Concept Videos
Somatic to iPS Cell Reprogramming
Inheritance of Chromatin Structures
Maintenance of the ES Cell State
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
Methods of Nuclear Reprogramming
Master Transcription Regulators

